Bone Support

Share Price

BONEX 296.00 SEK

+2.07%

09:52:05 CET Fri May 09 2025

  • Contact Us
Follow
  • US site
    • Global English Site
    • Global Swedish Site
    • US site
  • Bonesupport
    • Message from the CEO
    • Vision & Mission
    • Sustainability
    • History
    • Management
    • The Board
    • Our Partners
    • Careers
  • Products
    • CERAMENT® BONE VOID FILLER
    • CERAMENT® G with Gentamicin
    • Reimbursement Programs
    • OPTIONAL DELIVERY DEVICES
  • Innovation
    • Current Technology
    • Pipeline
    • CERTiFy Clinical Trial
  • Indications
  • Medical Professionals
  • Investors
  • Patients
    • Bone Grafts
    • BONE DEFECTS CAUSED BY TRAUMA
    • BONE DEFECTS CAUSED BY BENIGN BONE TUMORS
    • BONE DEFECTS CAUSED BY HIP AND KNEE REVISIONS
  • Events
  • Media
    • Press Releases
    • Publications and Resources
    • Multimedia
    • Media Archive
  • Financials
  • Financial Reports
  • Presentations
  • The Share
  • Analyst Coverage
  • Shareholders
  • Corporate Governance
  • Calendar
  • Q&A
  • Definitions
  • Capital Markets Day 2022
  • CAPITAL MARKETS DAY 2023

Financial Reports 2018

BONESUPPORT HOLDING AB was listed on Nasdaq Stockholm on 21st June 2017 and interim reports are published from Q2 2017.

PDF Icon

Annual Report 2018

17/04/2019

PDF Icon

Full Year Report 2018

27/02/2019

Net sales amounted to SEK 96.6 million (129.3), a decrease of 25%. Gross margin of 84% (87). Operating loss of SEK -174.4 million (-99.3).
PDF Icon

Interim Report, Q3, July - September2018

07/11/2018

Net Sales amounted to SEK 73.5 million (102.3), a decrease of 28%. Gross margin of 85.9% (87.9). Operating loss of SEK -128.1 million (-65.9).
PDF Icon

Interim Report, Q2, April - June 2018

26/07/2018

Net sales amounted to SEK 28.2 million (37.1), a decrease of 24%. Gross margin 87.4 % (87.2%). Operating loss of SEK -37.8 million (-18.4).
PDF Icon

Interim Report, Q1, January - March 2018

14/05/2018

Net sales amounted to SEK 31.1 million (32.5), an decrease of 4%. Gross margin 82.1 % (88.8%). Operating loss of SEK -33.1 million (-27.4).

©BONESUPPORT AB 2025. ALL RIGHTS RESERVED. CERAMENT and BONESUPPORT are registered Trademarks of BONESUPPORT AB.

  • Home
  • Contact Us
  • Privacy Policy
  • Cookie Policy